Research Article
The Prediction Model of Risk Factors for COVID-19 Developing into Severe Illness Based on 1046 Patients with COVID-19
Table 2
Influencing factors for COVID-19 patients developing severe illnesses.
| | | B | Standard error | Wald | Degree of freedom | Significance | Exp (B) | 95% CI of Exp (B) | | Lower limit | Upper limit |
| Step 1a | Age | 0.116 | 0.013 | 83.385 | 1 | <0.001 | 1.123 | 1.096 | 1.152 | Fever | 0.632 | 0.435 | 2.108 | 1 | 0.147 | 1.881 | 0.802 | 4.415 | Cough | 1.627 | 0.450 | 13.067 | 1 | <0.001 | 5.088 | 2.106 | 12.292 | Fatigue | 0.415 | 0.507 | 0.671 | 1 | 0.413 | 1.515 | 0.561 | 4.090 | Gastrointestinal symptoms | 0.080 | 0.934 | 0.007 | 1 | 0.932 | 1.083 | 0.174 | 6.753 | Chest tightness | 0.041 | 0.868 | 0.002 | 1 | 0.962 | 1.042 | 0.190 | 5.709 | Hypertension | −0.130 | 0.469 | 0.076 | 1 | 0.782 | 0.879 | 0.351 | 2.201 | Chronic kidney disease | −0.560 | 0.874 | 0.411 | 1 | 0.522 | 0.571 | 0.103 | 3.167 | Diabetes | 0.558 | 0.484 | 1.332 | 1 | 0.248 | 1.747 | 0.677 | 4.509 | Cerebrovascular disease | 0.797 | 0.983 | 0.657 | 1 | 0.418 | 2.219 | 0.323 | 15.242 | COPD | 1.971 | 0.779 | 6.398 | 1 | 0.011 | 7.178 | 1.559 | 33.055 | Tumor | 0.895 | 1.086 | 0.679 | 1 | 0.410 | 2.448 | 0.291 | 20.579 | Venous thrombosis | 5.092 | 2.227 | 5.231 | 1 | 0.022 | 162.753 | 2.071 | 12787.552 | Pneumothorax | 19.951 | 20619.154 | <0.001 | 1 | 0.999 | 461834480.538 | <0.001 | . | Acute liver injury | 0.511 | 0.630 | 0.658 | 1 | 0.417 | 1.667 | 0.485 | 5.733 | Electrolyte imbalance | 0.418 | 0.381 | 1.206 | 1 | 0.272 | 1.519 | 0.720 | 3.204 | Constant | −9.153 | 0.781 | 137.240 | 1 | <0.001 | <0.001 | | |
|
|
|